| 1 |
Yin F, Zhang H, Qi A, Zhu Z, Yang L, Wen G, Xie W. An exploratory study of CT radiomics using differential network feature selection for WHO/ISUP grading and progression-free survival prediction of clear cell renal cell carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.979613] [Reference Citation Analysis]
|
| 2 |
Janisch F, Kienapfel C, Fühner C, Klotzbücher T, Marks P, Hillemacher T, Meyer CP, Iwata T, Parizi MK, Sauter G, Fisch M, Shariat SF, Dahlem R, Rink M. Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data. Front Surg 2021;8:763271. [PMID: 34869564 DOI: 10.3389/fsurg.2021.763271] [Reference Citation Analysis]
|
| 3 |
Wu B, Kastl B, Cino-Ozuna AG, Springer NL, Thakkar R, Biller D, Whitehouse W, Easterwood L, Nguyen TA. Feline sarcomatoid renal cell carcinoma with peritoneal carcinomatosis and effusion. J Vet Diagn Invest 2021;:10406387211054826. [PMID: 34713776 DOI: 10.1177/10406387211054826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Yi X, Xiao Q, Zeng F, Yin H, Li Z, Qian C, Wang C, Lei G, Xu Q, Li C, Li M, Gong G, Zee C, Guan X, Liu L, Chen BT. Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma. Front Oncol 2020;10:570396. [PMID: 33585193 DOI: 10.3389/fonc.2020.570396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 5 |
Ficarra V, Caloggero S, Rossanese M, Giannarini G, Crestani A, Ascenti G, Novara G, Porpiglia F. Computed tomography features predicting aggressiveness of malignant parenchymal renal tumors suitable for partial nephrectomy. Minerva Urol Nephrol 2021;73:17-31. [PMID: 33200903 DOI: 10.23736/S2724-6051.20.04073-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 6 |
Tong K, Zhu W, Fu H, Cao F, Wang S, Zhou W, Liu C, Chen D, Fan S, Hu Z. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei. Histopathology 2020;76:1070-1083. [DOI: 10.1111/his.14084] [Cited by in Crossref: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 7 |
Tong K, Zhu W, Fu H, Cao F, Wang S, Zhou W, Liu C, Chen D, Fan S, Hu Z. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei. Histopathology 2020;76:1070-83. [PMID: 31997427 DOI: 10.1111/his.14084] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 8 |
Tanaka H, Ding X, Ye Y, Wang Y, Campbell RA, DeWitt-Foy ME, Suk-Ouichai C, Ward RD, Remer EM, Li J, Campbell SC. Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation. Eur Urol Oncol 2021;4:264-73. [PMID: 31439434 DOI: 10.1016/j.euo.2019.07.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 9 |
Alevizakos M, Gaitanidis A, Nasioudis D, Msaouel P, Appleman LJ. Sarcomatoid Renal Cell Carcinoma: Population-Based Study of 879 Patients. Clin Genitourin Cancer 2019;17:e447-53. [PMID: 30799129 DOI: 10.1016/j.clgc.2019.01.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 10 |
Ding X, Ma X, Jia Y, Li H, Wang Y. Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review. Oncol Lett 2018;16:1912-6. [PMID: 30008883 DOI: 10.3892/ol.2018.8867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 11 |
Kan A, Guo RP. The prognosis of subsequent surgical treatment in patients with sarcomatoid carcinoma in the liver: A retrospective study. Int J Surg 2018;55:145-51. [PMID: 29860126 DOI: 10.1016/j.ijsu.2018.05.736] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 12 |
Yu W, Wang Y, Jiang Y, Zhang W, Li Y. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases. BMC Cancer 2017;17:293. [PMID: 28449664 DOI: 10.1186/s12885-017-3275-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 13 |
Warpe BM. Leukemoid Reaction in Sarcomatoid Type of Renal Cell Carcinoma (SRCC): A Rare Case Report. ACP 2016;1. [DOI: 10.15406/acp.2016.01.00001] [Reference Citation Analysis]
|
| 14 |
Costa Neves M, Neofytou K, Giakoustidis A, Hazell S, Wotherspoon A, Gore M, Mudan S. Two cases of gallbladder metastasis from renal cell carcinoma and review of literature. World J Surg Oncol 2016;14:87. [PMID: 27005674 DOI: 10.1186/s12957-016-0843-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 15 |
Delahunt B, Samaratunga H, Kenwright DN. Histologic prognostic markers for renal cell neoplasia. Diagnostic Histopathology 2016;22:65-72. [DOI: 10.1016/j.mpdhp.2016.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
